LmjF.22.0810 from <i>Leishmania major</i> Modulates the Th2-Type Immune Response and Is Involved in Leishmaniasis Outcome
A novel serine/threonine protein kinase, LmjF.22.0810, was recently described in <i>Leishmania major</i>. After generating an <i>L. major</i> cell line overexpressing LmjF.22.0810 (named LmJ3OE), the ability of this novel protein to modulate the Th2-type immune response was a...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2020-10-01
|
| Series: | Biomedicines |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2227-9059/8/11/452 |